| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 09/05/2000 | US6114349 Substituted quinoline derivatives with antiviral action |
| 08/31/2000 | WO2000050427A1 Optically pure camptothecin analogues |
| 08/31/2000 | WO2000050426A2 Furo[3, 2-b]pyridines as 5-ht1f agonists |
| 08/31/2000 | WO2000050396A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 08/31/2000 | DE10008367A1 New 1-alkoxy-substituted hindered 2,2,6,6-tetramethylpiperidine group-containing amines useful as stabilizers for (thermoplastic) polymers, coatings, color photographic materials and printing inks |
| 08/31/2000 | CA2371876A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 08/31/2000 | CA2371784A1 5-ht1f agonists |
| 08/30/2000 | EP0690843B1 Formyl- or cyano- substituted indole derivatives having dopaminergic activity |
| 08/30/2000 | CN1055926C New acronycine analogues, process for their prepn. and pharmaceutical compsns. containing them |
| 08/29/2000 | US6111116 Dibenzorhodamine dyes |
| 08/29/2000 | US6111111 Intermediates in the synthesis of compounds having a pyridine skeleton in the molecule, such as viricidal furopyridine derivatives |
| 08/29/2000 | US6111108 Loading substrate containing campothecin into extraction vessel, introducing carbon dioxide at temperature and pressure exceeding critical temperature and pressure to cause carbon dioxide to reach supercritical state, separating product |
| 08/29/2000 | US6110955 Anticancer agent, antiproliferative agent, wound healing agent; treating cutaneous ulcers, gastrointestinal disorders, blood disorders such as anemias, immunomodulation, enhancing recombinant gene expression, inhibiting telomerase |
| 08/29/2000 | US6110928 Human or veterinary medicine |
| 08/29/2000 | US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 08/29/2000 | US6110914 Spiroazabicyclic heterocyclic compounds |
| 08/29/2000 | US6110910 Antiinflammatory agents, antiarthritic agents, antirheumatic agents, anticarcinogenic agents |
| 08/29/2000 | US6110909 Squalene synthetase inhibiting antilipemic agents |
| 08/29/2000 | US6110872 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 08/29/2000 | US6110400 Fulgimide compound and use thereof and composition containing said compound |
| 08/24/2000 | WO2000015992A3 Tube for lining pipes and channels, and a method and device for the production thereof |
| 08/23/2000 | EP1029859A1 N,N'-Disubstituted unsymmetrical cyclic urea and its use in therapy |
| 08/23/2000 | EP1028963A1 Novel substituted phenyl keto enols |
| 08/23/2000 | EP0698023B1 Fibrinogen receptor antagonists |
| 08/23/2000 | EP0652882B1 Anellated (oxa)hydantoines and their use as herbicides |
| 08/23/2000 | CN1264378A Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists |
| 08/23/2000 | CN1264367A Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests |
| 08/22/2000 | US6107488 Phenylimidazolidine preparation process |
| 08/22/2000 | US6107486 Method for purifying 20(S)-camptothecin |
| 08/22/2000 | US6107310 Heteroarylcarboxamide derivatives for treating CNS disorders |
| 08/22/2000 | US6107036 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 08/22/2000 | CA2042421C A method for the preparation in a non-racemic form of furo (3,4-c) pyridine derivatives |
| 08/17/2000 | WO2000047558A1 Amide compounds and medicinal use thereof |
| 08/16/2000 | EP1027338A2 New carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists |
| 08/16/2000 | EP1027332A1 Novel lactam metalloprotease inhibitors |
| 08/16/2000 | CN1263095A New tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 08/16/2000 | CN1055471C Substituted imidazolidines, their preparing process, and intermediates, their pharmaceutical compositions and there use |
| 08/15/2000 | US6103905 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| 08/15/2000 | US6103745 Useful for high fungicidal, insecticidal and acaricidal activity |
| 08/15/2000 | US6103738 Quinoline and quinazoline compounds useful in therapy |
| 08/15/2000 | US6103736 Showing an inhibitory action on gastric acid secretion and a protective action of gastric mucosa; 2-(hetero)aryl-3-aminoimidazo-(2,1-a)isoquinolines; antiulcer agents; |
| 08/15/2000 | US6103727 Pyrimidine derivatives and methods of making and using these derivatives |
| 08/15/2000 | US6103715 Compounds that bind to the dopamine d4 receptor and their use as anxiolytic agents, treatment for schizophrenia, and drug screening; side effect reductioon |
| 08/10/2000 | WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/10/2000 | WO2000046215A1 Benzazepine derivatives as alpha-v integrin receptor antagonists |
| 08/10/2000 | WO2000027822A3 Tricyclic pyrazole derivatives |
| 08/10/2000 | WO2000008026A3 Fungicidal fused bicyclic heterocycles |
| 08/10/2000 | CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/10/2000 | CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists |
| 08/09/2000 | EP1025102A1 Bicyclic kinase inhibitors |
| 08/09/2000 | EP1025092A2 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate |
| 08/09/2000 | EP0764159B1 C -4 amide substituted compounds and their use as therapeutic agents |
| 08/09/2000 | CN1262677A Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents |
| 08/08/2000 | US6100273 Water soluble camptothecin derivatives |
| 08/08/2000 | US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists |
| 08/08/2000 | US6100268 Vasoconstrictive dihydrobenzopyran derivatives |
| 08/03/2000 | WO2000044755A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 08/03/2000 | WO2000044743A1 Amide derivatives and drug compositions |
| 08/03/2000 | WO2000044728A1 Substituted bicyclic derivatives useful as anticancer agents |
| 08/03/2000 | WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS |
| 08/03/2000 | WO2000006146A9 Substituted anilide compounds and methods |
| 08/02/2000 | EP1024142A1 New sesquiterpene derivatives |
| 08/02/2000 | EP1023290A1 Synthesis of swainsonine salts |
| 08/02/2000 | EP1023269A1 Beta3-adrenoreceptor agonists, agonist compositions and methods of using |
| 08/02/2000 | EP1023268A1 Isoquinolines as urokinase inhibitors |
| 08/02/2000 | EP1023068A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 08/02/2000 | EP0885229B1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 08/02/2000 | EP0527889B1 Quinolizinone type compounds |
| 08/02/2000 | CN1261795A Compounds and methods |
| 08/02/2000 | CN1055089C Intermediate of protein kinase C inhibitor and its preparation |
| 08/01/2000 | US6096840 Gas phase polymerization process |
| 08/01/2000 | US6096750 Furopyrimidines and methods of making and using the same derivatives |
| 08/01/2000 | US6096729 Use of NK-1 receptor antagonists for treating amnestic disorders |
| 08/01/2000 | CA2178760C Hiv protease inhibitors |
| 07/27/2000 | WO2000043397A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 07/27/2000 | WO2000042852A1 Compounds and methods |
| 07/27/2000 | WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation |
| 07/27/2000 | CA2353903A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 07/26/2000 | EP1021448A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS |
| 07/26/2000 | EP1021418A1 Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| 07/26/2000 | EP1021407A1 Synthesis of clasto-lactacystin beta-lactone and analogs thereof |
| 07/26/2000 | EP1021185A1 Didhydropyrimidines and uses thereof |
| 07/26/2000 | CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists |
| 07/25/2000 | US6093826 Steroid receptor modulators |
| 07/25/2000 | US6093825 Combining an aniline, a silylating agent, and further condensing with a ketone in the presence of a catalyst |
| 07/25/2000 | US6093821 Process for preparing steroid receptor modulator compounds |
| 07/25/2000 | US6093815 Phenolic coupling and oxidative cyclization of an n-(3-hydroxy-4-alkoxy benzyl),2-(4-(alkoxyphenyl)ethylamine; optics; alzheimer's disease |
| 07/25/2000 | US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/25/2000 | US6093727 A selective agonists for human alpha 2 receptors for treating disorders as hypertension, pain, glaucoma, alcohol and drug withdrawal, ischemia, rheumatoid arthritis, migraine, cognitive deficiency, spasticity, diarrhea, nasal congestion |
| 07/25/2000 | US6093723 An immunomodulator for treating and preventing immune disorders, including autoimmune disease, inflammatory disease, organ transplant rejection and other disorders associated with il-2 mediated immune response |
| 07/25/2000 | US6093721 Amidino-camptothecin derivatives |
| 07/25/2000 | US6093714 An antiallergens for treatment and prevention of bronchial asthma, eczema, hives, allergic gastrointestinal troubles, allergic rhinitis, allergic conjunctivitis |
| 07/25/2000 | CA2169115C 1-¬2-(substituted vinyl)|-5h-2,3-benzodiazepine derivatives |
| 07/20/2000 | WO2000042045A2 Functionalized heterocycles as chemokine receptor modulators |
| 07/20/2000 | WO2000042044A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042026A1 Non-peptide glp-1 agonists |
| 07/20/2000 | WO2000042025A1 Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives |